NeuroMetrix
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of NeuroMetrix generated cash of -$6,084,868, which is less than the previous year. Cash used in financing activities reached the amount of $2,325,441 last year. Net change in cash is therefore -$2,603,074.
Cash Flow
| 2014 | -7.67M | -227.30K | 7.93M |
|---|---|---|---|
| 2015 | -13.09M | -594.60K | 16.93M |
| 2016 | -15.08M | -100.49K | 6.66M |
| 2017 | -12.65M | -163.09K | 12.91M |
| 2018 | 2.86M | -143.58K | 18.61K |
| 2019 | -3.62M | -48.07K | 15.10K |
| 2020 | -2.06M | 0 | 4.16M |
| 2021 | -2.07M | -131.71K | 19.55M |
| 2022 | -5.28M | -16.89M | 3.86M |
| 2023 | -6.08M | 1.15M | 2.32M |
NURO Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 4.33M | 22.57M | 5.22M | 3.12M | 6.78M | 4.04M | 3.94M | 12.46M | 9.22M | 9.19M |
Operating activities | ||||||||||
Net income | -6.52M | -4.41M | -2.28M | -2.09M | -3.77M | 23.60K | -12.85M | -14.91M | -9.18M | -7.76M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 55.71K | 49.39K | 76.37K | 89.95K | 124.01K | 169.71K | 262.33K | 251.32K | 222.59K | 145.1K |
Stock-based compensation expense | 699.50K | 477.06K | 698.17K | 599.11K | 190.33K | 0 | 209.69K | 225.40K | 302.41K | 289.87K |
| Deferred income tax benefit | 699.50K | 477.06K | 698.17K | 599.11K | 190.33K | 0 | 209.69K | 225.40K | 302.41K | 289.87K |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 127.94K | -335.95K | 23.47K | -35.33K | 734.62K | 1.31M | -310.6K | 69.09K | -162.47K | -189.31K |
Inventories | -7.86K | -1.26M | -154.41K | 112.43K | -897.73K | -719.30K | -117.40K | -163.15K | -409.34K | -116.70K |
Accounts payable | -152.57K | 84.04K | 141.72K | -583.34K | -572.42K | 572.15K | -8.11K | -267.58K | 478.76K | 199.97K |
Cash generated by operating activities | -6.08M | -5.28M | -2.07M | -2.06M | -3.62M | 2.86M | -12.65M | -15.08M | -13.09M | -7.67M |
Investing activities | ||||||||||
Purchases Of Investments | -29.75M | -40.93M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -183.54K | -23.18K | -131.71K | 0 | -48.07K | -143.58K | -163.09K | -100.49K | -594.60K | -227.30K |
Acquisitions Net | 0 | -24.06M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | 1.15M | -16.89M | -131.71K | 0 | -48.07K | -143.58K | -163.09K | -100.49K | -594.60K | -227.30K |
Financing activities | ||||||||||
Common Stock Issued | 2.32M | 3.86M | 19.55M | 4.16M | 15.10K | 18.61K | 12.91M | 6.66M | 20.14M | 7.93M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -3.20M | 0 |
Repayments of term debt | 0 | 0 | 0 | -773.2K | 0 | 0 | 0 | 0 | 0 | 0 |
Cash used in financing activities | 2.32M | 3.86M | 19.55M | 4.16M | 15.10K | 18.61K | 12.91M | 6.66M | 16.93M | 7.93M |
Net Change In Cash | -2.60M | -18.31M | 17.34M | 2.10M | -3.65M | 2.73M | 94.54K | -8.51M | 3.24M | 26.23K |
Cash at end of period | 1.73M | 4.25M | 22.57M | 5.22M | 3.12M | 6.78M | 4.04M | 3.94M | 12.46M | 9.22M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |